Stattin P - Search Results

1

Blood pressure and other metabolic syndrome factors and risk of brain tumour in the large population-based Me-Can cohort study.

Edlinger M, Strohmaier S, Jonsson H, Bjørge T, Manjer J, Borena WT, Häggström C, Engeland A, Tretli S, Concin H, Nagel G, Selmer R, Johansen D, Stocks T, Hallmans G, Stattin P, Ulmer H. Edlinger M, et al. Among authors: stattin p. J Hypertens. 2012 Feb;30(2):290-6. doi: 10.1097/HJH.0b013e32834e9176. J Hypertens. 2012. PMID: 22179083

2

Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.

Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M. Stattin P, et al. Int J Cancer. 2002 May 1;99(1):124-9. doi: 10.1002/ijc.10313. Int J Cancer. 2002. PMID: 11948503

3

Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden.

Stattin P, Palmqvist R, Söderberg S, Biessy C, Ardnor B, Hallmans G, Kaaks R, Olsson T. Stattin P, et al. Oncol Rep. 2003 Nov-Dec;10(6):2015-21. Oncol Rep. 2003. PMID: 14534736

4

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.

Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M. Tuohimaa P, et al. Among authors: stattin p. Int J Cancer. 2004 Jan 1;108(1):104-8. doi: 10.1002/ijc.11375. Int J Cancer. 2004. PMID: 14618623

5

High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.

Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M. Stattin P, et al. Int J Cancer. 2004 Jan 20;108(3):418-24. doi: 10.1002/ijc.11572. Int J Cancer. 2004. PMID: 14648709

6

High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.

Stattin P, Rinaldi S, Biessy C, Stenman UH, Hallmans G, Kaaks R. Stattin P, et al. J Clin Oncol. 2004 Aug 1;22(15):3104-12. doi: 10.1200/JCO.2004.10.105. J Clin Oncol. 2004. PMID: 15284261

7

Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.

Hultdin J, Van Guelpen B, Bergh A, Hallmans G, Stattin P. Hultdin J, et al. Among authors: stattin p. Int J Cancer. 2005 Feb 20;113(5):819-24. doi: 10.1002/ijc.20646. Int J Cancer. 2005. PMID: 15499634

8

Plasma leptin and breast cancer risk: a prospective study in northern Sweden.

Stattin P, Söderberg S, Biessy C, Lenner P, Hallmans G, Kaaks R, Olsson T. Stattin P, et al. Breast Cancer Res Treat. 2004 Aug;86(3):191-6. doi: 10.1023/B:BREA.0000036782.11945.d7. Breast Cancer Res Treat. 2004. PMID: 15567935

9

Chlamydial antibodies and risk of prostate cancer.

Anttila T, Tenkanen L, Lumme S, Leinonen M, Gislefoss RE, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Stattin P, Saikku P, Dillner J, Lehtinen M, Hakama M. Anttila T, et al. Among authors: stattin p. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):385-9. doi: 10.1158/1055-9965.EPI-03-0325. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734962

10

Prospective study of plasma enterolactone and prostate cancer risk (Sweden).

Stattin P, Bylund A, Biessy C, Kaaks R, Hallmans G, Adlercreutz H. Stattin P, et al. Cancer Causes Control. 2004 Dec;15(10):1095-102. doi: 10.1007/s10552-004-1480-7. Cancer Causes Control. 2004. PMID: 15801493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

521 results

Search Page

Filters